Paper1901649
Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.
Takeyama M and 6 others. Pharm Res, 1991. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors. Papers, record 1901649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1901649
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin | Major topic |
| Protease Inhibitors | Major topic |
| Administration, Topical | |
| Adult | |
| Animals | |
| Benzamidines | |
| Biological Availability | |
| Gabexate | |
| Guanidines | |
| Heart Arrest, Induced | |
| Humans | |
| Injections, Subcutaneous | |
| Iodine Radioisotopes | |
| Male | |
| Mice | |
| Mice, Hairless | |
| Ointments | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3927313 | Simultaneous determination of gabexate mesilate (Foy) and its catabolite in plasma and whole blood by reverse-phase high-performance liquid chromatography. | Pharm Acta Helv | 1985 | https://conductscience.org/library/papers/3927313 | PubMed |
| 2 | 488572 | Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site. | Diabetologia | 1979 | https://conductscience.org/library/papers/488572 | PubMed |
| 3 | 4032239 | [Stability studies on nafamstat mesilate in aqueous solution. I. Kinetic studies in various pH and temperature conditions]. | Yakugaku Zasshi | 1985 | https://conductscience.org/library/papers/4032239 | PubMed |
| 4 | 24271350 | Protein drugs: a revolution in therapy? | Pharm Res | 1986 | https://conductscience.org/library/papers/24271350 | PubMed |
| 5 | 4241908 | Diabetogenic action of streptozotocin: relationship of dose to metabolic response. | J Clin Invest | 1969 | https://conductscience.org/library/papers/4241908 | PubMed |
| 6 | 14036480 | Specific determination of blood glucose with o-toluidine. | Clin Chim Acta | 1962 | https://conductscience.org/library/papers/14036480 | PubMed |
| 7 | 6155578 | Resistance against subcutaneous insulin successfully managed with aprotinin. | Lancet | 1980 | https://conductscience.org/library/papers/6155578 | PubMed |
| 8 | 3891962 | Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat. | J Pharmacobiodyn | 1985 | https://conductscience.org/library/papers/3891962 | PubMed |
| 9 | 1270578 | Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects. | J Clin Endocrinol Metab | 1976 | https://conductscience.org/library/papers/1270578 | PubMed |
| 10 | 6482087 | Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. | Jpn J Pharmacol | 1984 | https://conductscience.org/library/papers/6482087 | PubMed |
| 11 | 2409262 | Fate of porcine and human insulin at the subcutaneous injection site. II. In vitro degradation of insulins in the subcutaneous tissue of the rat. | J Pharmacobiodyn | 1985 | https://conductscience.org/library/papers/2409262 | PubMed |
| 12 | 7000596 | Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin. | Diabetologia | 1980 | https://conductscience.org/library/papers/7000596 | PubMed |
| 13 | 7019707 | Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. | N Engl J Med | 1981 | https://conductscience.org/library/papers/7019707 | PubMed |
| 14 | 2682592 | Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans. | Pharm Res | 1989 | https://conductscience.org/library/papers/2682592 | PubMed |
| 15 | 4259678 | Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. | Biochim Biophys Acta | 1972 | https://conductscience.org/library/papers/4259678 | PubMed |
| 16 | 6553561 | New synthetic inhibitor to the alternative complement pathway. | Immunology | 1983 | https://conductscience.org/library/papers/6553561 | PubMed |
| 17 | 7391939 | Permeation of hairless mouse skin I: Experimental methods and comparison with human epidermal permeation by alkanols. | J Pharm Sci | 1980 | https://conductscience.org/library/papers/7391939 | PubMed |
| 18 | 6191020 | Pharmaceutical approach to subcutaneous dosage forms of insulin. | J Pharm Sci | 1983 | https://conductscience.org/library/papers/6191020 | PubMed |
| 19 | 700273 | Mobilization of subcutaneously injected tritiated insulin in rats: effects of muscular exercise. | Diabetologia | 1978 | https://conductscience.org/library/papers/700273 | PubMed |
| 20 | 6073660 | The specific inactivation of trypsin by ethyl p-guanidinobenzoate. | J Biol Chem | 1967 | https://conductscience.org/library/papers/6073660 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33942169 | A Two-Pore Physiologically Based Pharmacokinetic Model to Predict Subcutaneously Administered Different-Size Antibody/Antibody Fragments. | AAPS J | 2021 | https://conductscience.org/library/papers/33942169 | PubMed |
| 31817205 | Understanding Inter-Individual Variability in Monoclonal Antibody Disposition. | Antibodies (Basel) | 2019 | https://conductscience.org/library/papers/31817205 | PubMed |
| 31408633 | Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration. | J Pharm Sci | 2020 | https://conductscience.org/library/papers/31408633 | PubMed |
| 28707164 | Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers. | Pharm Res | 2017 | https://conductscience.org/library/papers/28707164 | PubMed |
| 27327034 | A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity. | Bioconjug Chem | 2016 | https://conductscience.org/library/papers/27327034 | PubMed |
| 22707818 | Noninvasive routes of proteins and peptides drug delivery. | Indian J Pharm Sci | 2011 | https://conductscience.org/library/papers/22707818 | PubMed |
| 12916897 | Influence of absorption promoters on pulmonary insulin bioactivity. | AAPS PharmSciTech | 2003 | https://conductscience.org/library/papers/12916897 | PubMed |
| 11785686 | Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats. | Pharm Res | 2001 | https://conductscience.org/library/papers/11785686 | PubMed |
| 9755890 | Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors. | Pharm Res | 1998 | https://conductscience.org/library/papers/9755890 | PubMed |
| 7937534 | Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats. | Pharm Res | 1994 | https://conductscience.org/library/papers/7937534 | PubMed |
| 2128896 | Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF. | Pharm Res | 1990 | https://conductscience.org/library/papers/2128896 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1901649
GET https://conductscience.org/api/papers/v1/1901649/references?page=2